nyse:abbv 2025

$AbbVie Announces Updated Results From Phase 2 EPCORE® NHL-6 Study Evaluating the Potential for Outpatient Monitoring of Epcoritamab in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma$

Pharmaceutical Investing

AbbVie Announces Updated Results From Phase 2 EPCORE® NHL-6 Study Evaluating the Potential for Outpatient Monitoring of Epcoritamab in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Investing News NetworkYour trusted source for investing success

nyse:abbv

AbbVie Declares Quarterly Dividend

AbbVie Announces Updated Results From Phase 2 EPCORE® NHL-6 Study Evaluating the Potential for Outpatient Monitoring of Epcoritamab in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Allergan Aesthetics Launches Campaign to Educate Consumers about Hyaluronic Acid Injectable Fillers

Health Canada Approves ELAHERE® for Certain Types of Platinum-Resistant Ovarian Cancers

AbbVie to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

RINVOQ® Receives Health Canada Notice of Compliance for Giant Cell Arteritis in adults

AbbVie to Acquire Gilgamesh Pharmaceuticals' Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline

AbbVie Announces Positive Topline Results from Second Phase 3 UP-AA Trial Evaluating Upadacitinib for Alopecia Areata

AbbVie Completes Acquisition of Capstan Therapeutics

SkinMedica® Unveils Its Newest Hydration Hero

AbbVie Announces $195 Million Investment to Expand Active Pharmaceutical Ingredient Manufacturing in the U.S.

Health Canada Approves AbbVie's RINVOQ® for the Treatment of Adults with Active Non-Radiographic Axial Spondyloarthritis

AbbVie Releases New Data Demonstrating Breadth of Its Gastroenterology Portfolio at 2023 Digestive Disease Week®

VIDEO - Marc Lichtenfeld: Short or Long Term, Know Why You’re in Gold

AbbVie’s VENCLEXTA Gets Health Canada Approval to Treat CLL

Latest News

Operational Update

Lode Gold Closes $1.51 Million Upsized Private Placement

CORRECTED: CHARBONE Hydrogen is Acquiring Hydrogen Production Assets and Closing a First Tranche of $1M Private Placement Financing

CORRIGE: CHARBONE Hydrogene acquiert des actifs de production d'hydrogene et cloture une premiere tranche d'un financement par placement prive de 1 M$

Purepoint Uranium Closes Final Tranche of $6 Million Private Placement

Outlook Reports

Featured Stocks

Locksley Resources

Westport

Alvopetro Energy

Aurum Resources

Electric Royalties

Saga Metals

Browse Companies